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IntroductIon
According to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), published in 2001, "chronic obstructive pulmonary disease (COPD) is a respiratory disease characterized by the presence of chronic airflow obstruction that is not fully reversible. 1 The airflow obstruction is usually progressive and associated with an abnormal inflammatory response of the lungs to inhaled particles or toxic gases. Over the last few years, COPD has had a great emphasis in view of the awareness regarding its importance as a morbidity and mortality factor. The World Health Organization (WHO) estimates that COPD affects 210 million people worldwide, with approximately 64 million symptomatic cases. 2 COPD symptoms are similar to asthma's -which is another chronic obstructive respiratory disease whose clinical features often overlap COPD's. However, in asthma, the airflow obstruction is reversible, as opposed to COPD, with poor response to bronchodilators observed in spirometry.
COPD is a consolidated challenge to public health in Brazil. In 2010, over 127.000 patients were admitted to public hospitals diagnosed with this disease, according to the International Classification of Diseases (ICD-10); and over 37.000 deaths were due to COPD, according to Mortality Information System/Sistema Único de Saúde (SUSBrazilian Unified Health System). The Global Burden of Disease Study projected that in 2020, COPD will account for 4.1 % of the total of disability-adjusted life years (DALYs) and will rank fifth in lost DALYs -after ischemic heart disease, major depression, traffic accidents and cerebrovascular disease. 3 The Platino study described the prevalence of COPD in five Latin American countries, including Brazil. It was estimated that 14.3% of a 85 million population over 40 years old was affected. 4 A regional follow-up of that study with the population from the city of São Paulo -using spirometry as a gold standard diagnostic test -demonstrated a COPD prevalence of 15.8%, 87.5% of which had never been previously diagnosed, revealing low awareness and underestimation of COPD as a major concern. 5 In a previous prevalence study using SUS database, Campos demonstrated a significant increase in COPD mortality in Brazil from 1980 to 1998. 6 In this study, the author reported a 3.3 fold overall increase in absolute mortality due to COPD, especially among patients aged 65 years and older, and high mortality rates in the country's South and Southeast regions. Hospital admission due to COPD had the highest mortality rates (12.2%) of all respiratory causes in the city of Sao Paulo from 1995 to 2000. 7 Given COPD's increasing importance as a cause of death in most countries, an updated analysis on COPD mortality is needed to support control and prevention policies.
objectIve
To update data and analyze mortality trends due to COPD in different Brazilian regions according to different age and gender groups, from 1989 to 2009.
methodS
In this study, data on COPD mortality from 1989 to 2009 was collected from the DATASUS (Departamento de Informática do SUS -Brazilian Health System Database) Mortality Information System of the Ministry of Health (SIM/DATASUS). For data selection, we used the International Classification of Diseases version 9 (ICD9) for deaths before 1996 (i.e., 1989-1995) and ICD10 for deaths thereafter. ICD9 included codes 490, 491, 492 and 496. For ICD10, J40, J41, J42, J43 and J44 codes were chosen. Using these codes, both the general standardized mortality rate (GSMR) and the specific mortality rate (SMR), disaggregated by gender, age or by the regional population estimation, were calculated annually using demographic stratified data according to Brazil's periodic census and historic population estimations provided by DATASUS. Rates were given per 100.000 individuals. While modeling polynomial coefficients, COPD mortality rates were considered as the dependent variable (Y), and calendar years as, the independent variable (X). As a measure of accuracy of the model, the determination coefficient (R 2 ) was used. The models were tested for linear (Y = β0 + β1X), quadratic (Y = β0 + + β1X β2X2), cubic (Y = β0 + β1X β2X2 + + β3X3) and exponential (Y = β0 + and β1X) fit. SPSS version 19 was used for statistical analysis. Trends were considered significant at the p < 0.05 level. In those models, β0 was the period average coefficient (intercept) and the β1, the average annual increment (linear effect coefficient).
reSultS Table 1 shows regression coefficients and statistical significance of COPD mortality rate trend according to gender, age, and region in Brazil. Figure 1 shows standard and gender COPD mortality rates in Brazil. GSMR increased from 1980 to 2004, with 19.84 deaths per 100.000 residents, but declined after that. COPD SMR according to gender shows an upward trend in both genders until 2004, reaching 24.52 male and 15.04 female deaths per 100.000 inhabitants; but again, declined after that.
The evolution of age-adjusted COPD mortality rates per 100.000 individuals of the same age group is illustrated in Table 1 . A significant difference in SMR was observed according to age groups. The segment which comprises 0 to 34 year olds showed SMR below 2 per 100.000 deaths of age-adjusted individuals; however, it shows a linear downward trend with decrease of 0.009 deaths per year in COPD SMR. The segment comprising 35 to 44 year olds showed mortality rate values ranging from 1. There is great heterogeneity in COPD SMR in all Brazilian regions, as shown in Figure 2 . The South region shows the largest COPD SMR throughout the sampling period, with a mean coefficient of 36.46 per 100.000 inhabitants and an increasing trend 
dIScuSSIon
This study shows a stabilization trend, or even a decline, in COPD mortality in Brazil, compared to a previous study using the same methodology. 6 Similar results have been published recently. A decrease of COPD mortality in both genders, from 1996 to 2007, had already been reported in Canada. 8 Additionally, data from England and Wales showed a reduction in COPD mortality in men, but an increase among women. 9 The decreasing trend mortality due to obstructive lung diseases in Brazil had already been reported in a previous study; however, it couldn't be compared to the present study, as it included ICD data related to asthma (J45-0). 10 This is the first study using this methodology to report a decrease in COPD trends in Brazil, according to the authors' knowledge.
Epidemiological studies using death certificates are biased information. Under or misreporting COPD deaths cannot be excluded, especially in regions where coverage of vital statistics depends on the hospital structure. Moreover, there are other information bias due to diagnostic limitations and inaccuracies at the time of the death certificate. [11] [12] [13] Another possible source of information bias refers to different disease interpretations provided by ICD, which consequently leads to different results in COPD epidemiology. Additionally, ICD change from version 9 to 10, in 1996, may have led to different results. To decrease information biases, this review was made using the same study parameters of COPD mortality in Brazil, from 1989 to 1998. 6 This study shows a current stabilization or decrease trend in COPD mortality in Brazil, based on SUS database. After the steady increase starting in 1989, there was an inflection point in the curve in 1998. When looking at the mortality curve according to gender, there is a declining trend after 2004 in both genders. In 1998, the COPD mortality rate ratio between male/female decreased from 1.64, to 1.51 in 2009. This finding contrasts with the increased trends in COPD mortality among women, compared to men, as reported in North American epidemiological studies (Table 1 and Figure 1 ). 14, 15 Not only gender, but also all age groups, showed a stabilization or decrease trend in COPD deaths after 1999 (Table 1 and Figure 2 ). The age group comprising 65 yearolds or older had higher COPD SMR rates. This age group is historically very representative in overall COPD deaths. 6 It fits well in a quadratic model (R 2 = 0.739) with a declining turning point after 1999, and it significantly contributed to the trend's overall decline. With the increase in life expectancy, further studies are needed in this age group to monitor control measures of this important disease in Brazil's aging population.
The causes of this decrease in COPD mortality are still unknown. They can be associated to new health policies aiming at providing better access for patients to health services, as demonstrated in some other avoidable mortality diseases. 16 The introduction of new therapies, such as oxygen therapy and new drugs, has also shown an increase in survival among COPD patients in moderatesevere stages, 1, 17 and it could be contributing to the change in COPD mortality trend.
COPD epidemiology shows a close relationship with smoking and other domiciliary and occupational exposures. Smoking is the main risk factor, accounting for approximately 90% of COPD patients; and, consequently, the most studied risk factor (1, 2). As a result, a potential contributing factor to the decline in COPD mortality may be related to the changes in smoking habits in Brazil during the analyzed period. According to a non-continued analysis across three different studies on smoking prevalence among the population -the Brazilian Health and Nutrition Survey (PNSN -Pesquisa Nacional de Saúde e Nutrição), 18 Further research on the smoking prevalence in Brazil showed a reduction in smoking habits among all age groups, the sharpest decline being among the youngest (< 35 years old) and the oldest (> 65 years old). 21 PNAD 2008 -with emphasis on smoking -shows data of great interest for understanding the Brazilian smoker profile. It demonstrates an inverse relationship between smoking and per capita income, especially in the South and Southeast regions. This study also suggests that the educational level influences the age people start smoking -among people with no education or less than a year of study, the proportion of those who started smoking before the age of 15 reaches 40.8%. 22 In a recent meta-analysis on the subject, Godtfredsen et al. report an increased survival time and a decreased Male   General   1989  1990  1991  1992  1993  1994  1995  1996  1997  1998  1999  2000  2001  2002  2003  2004  2005  2006  2007  2008 rate of lung function loss, even in severe COPD, compared with those who did not stop smoking. 23 However, the expected time between the decrease in smoking prevalence observed in a population and its subsequent decline in mortality rates due to tobacco-associated mortalities among that population remains largely speculative.
SMR/100.000 inhab Female
The global initiative against COPD recommends influenza vaccination in patients with COPD with level of evidence A. 1 In that sense, in 1999, a mass vaccination against influenza (seasonal influenza) was established in Brazil for individuals older than 65 years as a strategy of the Ministry of Health. This strategy would potentially benefit COPD patients within this age group who had a higher mortality rate, even those without medical diagnosis of COPD. In a time series study, Francis et al. investigated the impact on mortality among the elderly due to this vaccination. The authors demonstrated a reduction in mortality from 2000 to 2001; however, it increased again after 2002, especially in the age group above 75 years old. 24 Two other studies, one conducted in the state of Ceará and the other in the state of São Paulo, showed similar results with a significant decrease in the number of deaths and in mortality rate due to respiratory and cardiac causes from 2000 to 2001, with increased mortality in later years. 25, 26 A noteworthy study on mortality among the elderly in Brazil from 1980 to 2005, shows an increase in mortality related to influenza among the elderly, more pronounced in the South and Southeast regions, and among men older than 80 years, despite vaccination. 27 The reasons for these mixed results after vaccination campaigns are deficiencies in the coverage of the elderly population at risk 28 and immunosuppressive factors related to the aging immune system, reducing vaccine protection. 29 
concluSIon
This study shows a general trend towards stabilization in the number of COPD deaths in Brazil, from 1989 to 2009, concurrent with a reduction in smoking prevalence and the introduction of mass vaccination against influenza for the elderly in the same period. Despite the reduction of about 50% in the number of smokers in Brazil during the same period, it is not yet possible to correlate this fact with the development of COPD mortality due to lack of data continuity on smoking. However, continued efforts must be maintained as a public health priority in smoking prevention, especially among the most vulnerable classes, as well as to implement measures to extend coverage rates of vaccination campaigns against influenza to reduce COPD mortality. 
